Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Abstract

The intracellular protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a serious disorder that affects millions of people in Latin America. Cell invasion by T. cruzi and its intracellular replication are essential to the parasite's life cycle and for the development of Chagas disease. Here, we present evidence suggesting the involvement of the host's cyclooxygenase (COX) enzymes during T. cruzi invasion. Pharmacological antagonists for COX-1 (aspirin) and COX-2 (celecoxib) caused marked inhibition of T. cruzi infection when rat cardiac cells were pretreated with these nonsteroidal anti-inflammatory drugs (NSAIDs) for 60 min at 37°C before inoculation. This inhibition was associated with an increase in the production of NO and interleukin-1β and decreased production of transforming growth factor β (TGF-β) by cells. Taken together, these results indicate that COX-1 more than COX-2 is involved in the regulation of anti-T. cruzi activity in cardiac cells, and they provide a better understanding of the influence of TGF-β-interfering therapies on the innate inflammatory response to T. cruzi infection and may represent a very pertinent target for new therapeutic treatments of Chagas disease.

• Authors: Aparecida D Malvezi, Carolina Panis, Rosiane V da Silva, Rafael Carvalho de Freitas, Maria I Lovo-Martins, Vera L H Tatakihara, Nágela G Zanluqui, Edecio Cunha Neto, Samuel Goldenberg, Juliano Bordignon, Sueli F Yamada-Ogatta, Marli C Martins-Pinge, Rubens Cecchini, Phileno Pinge-Filho
• Journal: Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 58 Issue 10 Pg. 6157-64 (Oct 2014) ISSN: 1098-6596 [Electronic] United States
• PMID: 25092706 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Interleukin-1beta
• Pyrazoles
• Sulfonamides
• Transforming Growth Factor alpha
• Transforming Growth Factor beta
• Nitric Oxide
• Cyclooxygenase 1
• Cyclooxygenase 2
• Celecoxib
• Aspirin

Topics

• Animals
• Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
• Aspirin (pharmacology)
• Celecoxib
• Cell Line
• Cell Survival (drug effects)
• Cells, Cultured
• Cyclooxygenase 1 (metabolism)
• Cyclooxygenase 2 (metabolism)
• Enzyme-Linked Immunosorbent Assay
• Immunity, Innate (drug effects)
• Immunohistochemistry
• Interleukin-1beta (metabolism)
• Myoblasts, Cardiac (parasitology)
• Nitric Oxide (metabolism)
• Pyrazoles (pharmacology)
• Rats
• Sulfonamides (pharmacology)
• Transforming Growth Factor alpha (metabolism)
• Transforming Growth Factor beta (metabolism)
• Trypanosoma cruzi (drug effects, immunology, pathogenicity)